The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
about
Effectiveness of second generation antipsychotics: a systematic review of randomized trialsCircumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studiesAntiglucocorticoid and related treatments for psychosisAntiglucocorticoid and related treatments for psychosisShould cognitive deficit be a diagnostic criterion for schizophrenia?Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patternsCognitive dysfunction in bipolar disorder and schizophrenia: a systematic review of meta-analysesWhat does schizophrenia teach us about antipsychotics?The cytokine model of schizophrenia: emerging therapeutic strategiesNeuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidolAssociation of typical versus atypical antipsychotics with symptoms and quality of life in schizophreniaIncreased prolactin levels are associated with impaired processing speed in subjects with early psychosisA dimensional approach to modeling symptoms of neuropsychiatric disorders in the marmoset monkey.Cognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia.Mouse pharmacological models of cognitive disruption relevant to schizophrenia.Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests.Nicotine ameliorates NMDA receptor antagonist-induced deficits in contextual fear conditioning through high-affinity nicotinic acetylcholine receptors in the hippocampus.Antipsychotic dose and diminished neural modulation: a multi-site fMRI study.Molecular targets for treating cognitive dysfunction in schizophrenia.Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia.Prototypical antipsychotic drugs protect hippocampal neuronal cultures against cell death induced by growth medium deprivation.Improvement and decline of cognitive function in schizophrenia over one year: a longitudinal investigation using latent growth modelling.Excess of transmission of the G allele of the -1438A/G polymorphism of the 5-HT2A receptor gene in patients with schizophrenia responsive to antipsychotics[Treatment of cognitive deficits in schizophrenia. Part 2: Pharmacological strategies].Cognitive impairment in affective psychoses: a meta-analysisThe effects of galantamine on psychopathology in chronic stable schizophrenia.Treating cognitive dysfunction in patients with schizophreniaEffect of second-generation antipsychotics on cognition: current issues and future challenges.Cognitive effects of atypical antipsychotic drugs in first-episode drug-naïve schizophrenic patientsSubjective rating of working memory is associated with frontal lobe volume in schizophrenia.Integrated psychological therapy (IPT) for schizophrenia: is it effective?Fine-tuning of awake prefrontal cortex neurons by clozapine: comparison with haloperidol and N-desmethylclozapine.Cognitive deficits in psychiatric disorders: Current status.Cognitive neurosciences: A new paradigm in management and outcome of schizophreniaEarly signs, diagnosis and therapeutics of the prodromal phase of schizophrenia and related psychotic disordersTreatment of negative and cognitive symptoms.Cognitive effects of risperidone in children with autism and irritable behavior.Phenotypic markers as risk factors in schizophrenia: neurocognitive functions.Dopamine D2 receptor occupancy and cognition in schizophrenia: analysis of the CATIE data.
P2860
Q21260262-B4D68ADD-04C9-477A-ADFE-330FDE0A0E52Q22251051-A5FCEB15-A8BB-4028-9424-D38197B25EA9Q24186594-13DBB433-BF47-425D-B21C-93238358EED2Q24243495-C95C8918-93BC-4D3C-AA4B-9DD985028DDFQ24597744-80BB8055-0856-491E-8892-93D81440CEB4Q24802626-EBED9BF5-8D7A-4BD4-A1D5-2635EEE8DF20Q26771515-C2B1FDAD-4291-4AFD-9498-7C11C81B24FFQ26823906-C59F7CE8-7B57-493B-B68B-782760B5F607Q26865996-69ADC4F7-396E-4CE7-B6C2-C59CAE6F815AQ28362116-4E560A09-1E44-494B-9D4B-A04709CD802BQ28483750-5E420697-F7E4-4745-A8BA-421202DC6790Q28540093-A9F00704-6920-43EA-AE68-27A2716D2ECAQ30356275-D82DF1DA-44F4-4350-9E8E-E8089FC2D965Q30376510-9911AA4D-AB3D-40DE-B215-63333C2B63CAQ30457807-93093E01-04CD-42A6-96B2-FDA18EA21657Q30468652-563AD05E-E055-44BE-86B3-F6D4C9005077Q30470074-184FFF78-7D2A-41A0-9C6E-40DC61A491A7Q30475844-9882CDA0-F052-4E04-B8F5-41132D291D27Q30491310-6642CD48-39D7-492F-BC32-F703714C513AQ30501297-92D079BE-B26D-4C0C-96A1-2EF1D095970FQ33223628-70E02354-CDFA-4D5B-A47B-99108B1DF361Q33238062-CF8D652A-763A-43DF-A615-3B4A1FBBAD34Q33284145-240D23AA-C936-44EC-BAA2-B422B41E875AQ33338971-F69DCD84-AED6-49B0-B1C4-B81FB7E1B74FQ33535963-799E4FD9-9F64-4702-A2D6-FC639A91F9A9Q33566109-3E5B4C35-46E4-4801-A360-5B4D325F19ECQ33724801-B16945F9-008B-46B1-8762-E436742354FFQ33877844-0C1EA8B9-D274-44B4-A2E5-7BBD20A25738Q33888153-09AFA617-50EE-4C7C-A33D-F43ED9A056ABQ33936458-C0572882-00D1-4DAA-8155-52DEF30C67CFQ33976468-4BE247C3-D569-46A1-A03F-DE1F17A1BABFQ33998636-2A7C1094-6F01-4111-B4FF-E5B87978E55AQ34021750-D6EAB9CD-7A52-4B08-84E7-F43A42098E0CQ34034623-E8F4BE3C-405E-4350-9F19-94C25EA3FDBEQ34082617-27C5A280-FA4A-4928-A299-7997FA67B430Q34095720-27A34FC0-9066-4860-BDBE-5FE479B657A9Q34108164-B6D6F7D1-369C-4E02-9CBB-ACD9C0C534B1Q34112075-B627AC53-640D-4388-A433-A40B9BBAB67CQ34113098-40B2893E-AF1E-4E95-AE24-9F71CA42E0DCQ34145251-8FFC606B-A75E-45B7-ADFF-C7507B61FCB9
P2860
The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis.
description
1999 nî lūn-bûn
@nan
1999 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The effects of atypical antips ...... a: a review and meta-analysis.
@ast
The effects of atypical antips ...... a: a review and meta-analysis.
@en
type
label
The effects of atypical antips ...... a: a review and meta-analysis.
@ast
The effects of atypical antips ...... a: a review and meta-analysis.
@en
prefLabel
The effects of atypical antips ...... a: a review and meta-analysis.
@ast
The effects of atypical antips ...... a: a review and meta-analysis.
@en
P2093
P1476
The effects of atypical antips ...... a: a review and meta-analysis.
@en
P2093
P304
P356
10.1093/OXFORDJOURNALS.SCHBUL.A033374
P407
P577
1999-01-01T00:00:00Z